Comment on “Drug Screening for ALS Using Patient-Specific Induced Pluripotent Stem Cells”
Bilican B, Serio A, Barmada SJ, Nishimura AL, Sullivan GJ, Carrasco M, Phatnani HP, Puddifoot CA, Story D, Fletcher J, Park IH, Friedman BA, Daley GQ, Wyllie DJ, Hardingham GE, Wilmut I, Finkbeiner S, Maniatis T, Shaw CE, Chandran S. Comment on “Drug Screening for ALS Using Patient-Specific Induced Pluripotent Stem Cells”. Science Translational Medicine 2013, 5: 188le2. PMID: 23740897, PMCID: PMC3936961, DOI: 10.1126/scitranslmed.3005065.Peer-Reviewed Original ResearchAmyotrophic Lateral SclerosisDrug Evaluation, PreclinicalHumansInduced Pluripotent Stem CellsMotor Neurons